(Press-News.org) New research to be presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) suggests that living in a rural environment in the first five years of life could increase the risk of developing type 1 diabetes compared with living in urban environments. The study is by Samy Sebraoui and Professor Soffia Gudbjornsdottir, University of Gothenburg, Sweden, and colleagues.
Type 1 diabetes (T1D) is a chronic autoimmune disease where the body's immune system mistakenly attacks and destroys insulin-producing cells in the pancreas, called beta cells. This leads to little to no insulin production, a hormone crucial for regulating blood sugar levels. Without sufficient insulin, glucose (sugar) builds up in the bloodstream, causing hyperglycaemia (high blood sugar). T1D is typically diagnosed in childhood, adolescence, or young adulthood, but can occur at any age. Most people with the condition quickly progress to needing insulin replacement therapy for the rest of their lives.
Sweden has the second highest global incidence of T1D, with geographical variation suggesting environmental risk factors. Previous studies have focused on patient location at diagnosis, and only very few at the time of birth or before clinical diagnoses. This new study explores T1D incidence in Sweden based on where people have lived over time, following patients from birth to diagnosis to identify high- and low-risk clusters over different life periods.
All patients diagnosed with T1D during 2005-2022 (ages 0-30 years) were identified in the Swedish National Diabetes Register. All residential addresses from birth to diagnosis were then identified by Statistics Sweden. Statistical analysis was used to identify significant high- and low-risk clusters (see figure). A technique known as zonal statistics analysis was used to identify the land use / land cover characteristics of all identified clusters for the first five years of life exposure window.
The researchers found that 21,774 patients aged 0 to 30 years were diagnosed with T1D 2005-2022, 58 % were male; and 15,426 (around three quarters) were under 18 years old at diagnosis. The mean age at diagnosis was 13.6 yrs (males 14.1, females 12.9). 24 % of patients had relocated to a different municipality from birth to diagnosis.
Based on the residential location of all patients at the diagnosis of type 1 diabetes, 4 significant high-risk clusters were identified, all located centrally in the country (all in the countryside, away from urban centres), where the relative risk of developing T1D was between 30% and 80% higher compared to what would be expected from national averages (Fig 1a). No high-risk clusters were observed in people in major cities.
On the contrary, significant low-risk clusters were found in the largest cities, where the risk of developing T1D was found to be 20% to 50% lower (within the largest cities such as Stockholm, Gothenburg and Malmö). The authors say: “This finding was unexpected and highlights the need for environmental studies to investigate potential risk factors in rural areas, as well as possible protective factors in urban settings. In Sweden, we have access to highly detailed environmental data covering the entire country, providing a unique opportunity to better understand the development of type 1 diabetes.”
Then a second analysis, based on the main residential location during the first 5 years of life (regardless of age of diagnosis), 11 high-risk clusters were identified, all rural, with an increased risk of developing T1D of between 20% and 2.7 times higher compared with national averages. The northern regions had the highest relative risks. For the same time period, 15 low-risk clusters were observed, all in cities across the country, where risk of developing T1D was 20% to 88% lower than national averages - the very lowest risk being found in middle-sized cities in southern Sweden - (Fig 2b) – the cities with the lowest risk being Växjö (88% lower); Norrköping (64% lower) and Halmstad (61% lower).
The land use / land cover analysis conducted by the authors revealed notable differences between high- and low-risk clusters for the first 5 years of life. High-risk clusters are characterised by land covered by forest or used in agriculture, whereas low-risk clusters are dominated by urban and open land.
The authors say: “There is a clear geographical variation in the incidence of type 1 diabetes in Sweden. The first 5 years of life exhibited the strongest association with high- and low-risk clustering. Our findings facilitate further research into environmental factors potentially influencing development of type 1 diabetes. We hypothesise that the exposure of environmental factors, predominantly in rural areas and primarily during the first five years of life, elevates the risk for developing type 1 diabetes.”
They discuss some possible theories that can be explored in future studies, saying: “Viral infections are more common in early life in urban areas and that could protect a person from future autoimmune diseases including type 1 diabetes. Living in rural areas could be associated with more exposure, for example, to pesticides and allergens. This is only speculation, but we have very good data to be able to investigate this in detail in future studies.”
They conclude: “These findings were previously unknown and unexpected - it was a surprise that that living in larger cities came with a lower future risk of type 1 diabetes. We will study in detail different environmental factors that might be protective or increase risk. We will also look into different lifestyles in urban versus rural areas.”
END
Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes
2025-08-01
ELSE PRESS RELEASES FROM THIS DATE:
Editorial urges deeper focus on heart-lung interactions in pulmonary vascular disease
2025-08-01
DENVER - A new editorial published in Comprehensive Physiology underscores the critical importance of understanding heart-lung interactions in pulmonary vascular disease (PVD). Tim Lahm, MD, a pulmonologist and researcher at National Jewish Health, along with a team of esteemed colleagues from institutions across the country, urges the scientific community to confront the major knowledge gaps that hinder progress in improving patient outcomes. The editorial, titled "Towards a Better Understanding of Heart-Lung Interactions in Pulmonary ...
Five University of Tennessee faculty receive Fulbright Awards
2025-08-01
Five faculty members at the University of Tennessee, Knoxville — Christopher Cherry, Virginia Corrigan, Bernard Issa, Hector Pulgar and Tong (Toni) Wang — have been selected to receive Fulbright U.S. Scholar Program awards for the 2025-26 academic year from the U.S. Department of State and the Fulbright Foreign Scholarship Board.
Fulbright U.S. Scholars are faculty, researchers, administrators and established professionals teaching or conducting research in affiliation with institutes abroad. Fulbright Scholars engage in ...
5 advances to protect water sources, availability
2025-08-01
Water is an essential requirement for life on Earth — it supports everything from cellular processes to ecosystems. Five papers published in ACS journals provide new insights to help protect natural water sources and ensure that more people have access to safe drinking water. Reporters can request free access to these papers by emailing newsroom@acs.org.
Reducing salt contamination of tidal rivers. Across the globe, the saltwater portion of tidal rivers — which rise and fall with the ocean tides — has been traveling farther upstream in the last few decades. Researchers publishing in Environmental ...
OU Scholar awarded Fulbright for Soviet cinema research
2025-08-01
University of Oklahoma Associate Professor Dustin Condren, Ph.D., has been named a 2025-2026 Fulbright U.S. Scholar by the U.S. Department of State and the Fulbright Foreign Scholarship Board.
Condren is among around 400 scholars selected nationwide for the prestigious international award. The Fulbright Scholars program aims to promote mutual understanding between the people of the U.S. and those from other nations. Candidates are chosen based on their academic achievements and the strength of their proposed project.
“We are immensely proud of Dr. Condren for being ...
Brain might become target of new type 1 diabetes treatments
2025-08-01
More than a decade ago, researchers found that an acute complication of type 1 diabetes, diabetic ketoacidosis (DKA), can be resolved with the hormone leptin, even in the absence of insulin.
An analysis published today in The Journal of Clinical Investigation explains how leptin affects the brain and how it might be used in future therapeutics.
DKA happens when the body is unable to make insulin and begins to break down fat for fuel. This can lead to a life-threatening buildup of sugar (glucose) and ketoacids in the blood. Doctors have typically administered insulin to address ...
‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts
2025-08-01
Oysters and mangroves are both essential to protecting and restoring Florida’s coastlines that they call home, including defending them against storms.
As mangrove populations are increasing due to successful restoration efforts and favorable weather, however, their strong comeback may pose unintended consequences for oysters, according to new research from UCF graduate student Katherine Harris and Pegasus Professor Linda Walters published in the Marine Ecology Progress Series.
To protect Florida’s coastlines, the researchers hope their new findings can initiate efforts ...
Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes
2025-08-01
In recent years, doctors and scientists are increasingly studying long-lasting illnesses that begin after someone recovers from an infection. Two of the most well-known examples are long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
It has been estimated that 400 million people, globally, may have Long COVID, and nearly half of them meet criteria for ME/CFS.
These conditions were often misunderstood or overlooked in the past, but that is starting to change. Researchers are now studying them as part of a larger group of illnesses called post-acute infection syndromes, or PAISs.
A new review by Mass General Brigham investigator Anthony L Komaroff, ...
Study reveals hidden drivers of asthma flare-ups in children
2025-08-01
A recent multicenter clinical trial has uncovered inflammatory pathways that contribute to asthma flare-ups in children that occur despite treatment, according to findings published in JAMA Pediatrics.
Eosinophilic asthma is characterized by high levels of eosinophils, a type of white blood cell involved in the body’s immune response. While eosinophils typically help fight infections, in eosinophilic asthma, they accumulate in the lungs and airways, causing chronic inflammation, swelling and damage to the respiratory system.
Eosinophilic asthma is driven by type 2 (T2) inflammation, an immune response ...
Physicists decode mysterious membrane behavior
2025-08-01
Cell membranes cradle, protect, and gatekeep living cells. Membranes can even affect how a cell behaves.
But membranes’ own erratic behavior has puzzled scientists for years.
Turns out, it’s all about perspective: When physicist Rana Ashkar’s team members looked at how membranes behave on the nanoscale, they were able to identify unified biophysical laws that membranes have adhered to all along.
Published in Nature Communications, these findings have significant implications for disease ...
New insights about brain receptor may pave way for next-gen mental health drugs
2025-08-01
New York, NY [August 1, 2025]— In a discovery that could guide the development of next-generation antidepressants and antipsychotic medications, researchers at the Icahn School of Medicine at Mount Sinai have developed new insights into how a critical brain receptor works at the molecular level and why that matters for mental health treatments.
The study, published in the August 1 online issue of Science Advances, focuses on the 5-HT1A serotonin receptor, a major player in regulating mood and a common target of both traditional antidepressants and newer therapies such as psychedelics. Despite its ...